'Quick news on Pharma Industry' Chinese Covid-19 Vaccine show promising results
1.WHO defends data after concluding Gilead's remdesivir flopped Covid-19 trial:- Gilead sciences Inc has questioned the findings that concluded remdesivir does not help patients who have been admitted to hospital, saying the "emerging (WHO) data appears inconsistent". Gilead was given data from the United Nations health agency's trial 10 days ago, to give it an opportunity to react. 2. Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection:- Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Fingolimod capsules, (Gilenya) in the strengths of 0.5 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing. 3. Chinese Covid-19 vaccine candidate shows promise in human trial: Study:- The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years and found that antibody responses were induced in a...